Drugs / Sinovac rabies vaccine
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07416110 | Mar → Sep 2026 overdue | — | Sinovac Biotech Co., Ltd | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT07357545 | Aug 2021 → Sep 2022 | — | Sinovac Biotech Co., Ltd | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sinovac rabies vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07357545 ↗ |
| Known as | Rabies Vaccine (Serum-free Vero Cell) | “Three batchs of Rabies Vaccine (Serum-free Vero Cell), Freeze-dried using five doses of PEP schedules” NCT07416110 ↗ |
| Modality | Vaccine | “Sinovac rabies vaccine” NCT07357545 ↗ |